Hearing: “Office of National Drug Control Policy: Reauthorization in the 115th Congress"

Committee on Oversight and Government Reform

Wednesday, July 26, 2017 (10:30 AM)

Meeting was rescheduled to the time and date listed above.
1100 LHOB
Washington, D.C.

Witnesses

Mr. Richard Baum
Acting Director, Office of National Drug Control Policy

Added 08/07/2017 at 03:08 PM
  • Baum Statement [PDF] Added 08/07/2017 at 03:08 PM

Mr. Don Flattery
Addiction Policy Advocate and Impacted Parent

Added 08/07/2017 at 03:08 PM
  • Flattery Statement [PDF] Added 08/07/2017 at 03:08 PM
  • Flattery Truth in Testimony [PDF] Added 08/07/2017 at 03:08 PM

Dr. Keith Humphreys Ph.D.
Professor of Psychiatry and Behavioral Sciences, Stanford University

Added 08/07/2017 at 03:08 PM
  • Humphreys Statement [PDF] Added 08/07/2017 at 03:08 PM
  • Humphreys Truth in Testimony [PDF] Added 08/07/2017 at 03:08 PM
  • Humphreys Biography [PDF] Added 08/07/2017 at 03:08 PM

Ms. Diana Maurer
Director of Justice and Law Enforcement Issues, U.S. Government Accountability Office

Added 08/07/2017 at 03:08 PM
  • Maurer Statement [PDF] Added 08/07/2017 at 03:08 PM
  • Maurer Biography [PDF] Added 08/07/2017 at 03:08 PM

Hearing Record

  • 2017-07-26 Office of National Drug Control Policy Reauthorization in the 115th Congress [PDF] Added 02/21/2018 at 01:22 PM

First Published: July 20, 2017 at 09:28 AM
Last Updated: February 21, 2018 at 01:22 PM